A two-state receptor model for the interaction between angiotensin II type 1 receptors and non-peptide antagonists

被引:51
作者
Vauquelin, G [1 ]
Morsing, P
Fierens, FLP
De Backer, JP
Vanderheyden, PML
机构
[1] Free Univ Brussels, Dept Mol & Biochem Pharmacol, Rhode St Genese, Belgium
[2] AstraZeneca, Dept Cardiovasc Pharmacol, Molndal, Sweden
关键词
AT(1) antagonists; CHO cells; inositol phosphate; candesartan; irbesartan; EXP3174; losartan; surmountable; insurmountable;
D O I
10.1016/S0006-2952(00)00546-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The interaction between non-peptide antagonists and the human angiotensin II type 1 (AT(1)) receptor in CHO-K1 cells was investigated by incubating the cells with antagonist, followed by a brief exposure to angiotensin II and measurement of the resulting inositol phosphate accumulation. The experimental data, expressed either as angiotensin II concentration-response curves or as antagonist concentration-inhibition curves, were in good agreement with computer-generated data according to a single-state model for the surmountable antagonist losartan and according to a two-step. two-state receptor model for the insurmountable antagonists candesartan, EXP3174. and irbesartan. Experimental and computer-generated data concerning the simultaneous exposure of the receptors to EXP3174 and losartan indicated that losartan produced a concentration-dependent restoration of the maximal response (angiotensin II concentration-response curves) as well as a rightward shift of the insurmountable portion of the EXP3174 inhibition curves, thus counteracting the higher-affinity EXP3174 binding. In conclusion. these findings provide further support for the concept that insurmountable and surmountable AT(1) antagonists are mutually competitive and that insurmountable antagonist-receptor complexes may adopt different states, (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:277 / 284
页数:8
相关论文
共 32 条
[31]  
WONG PC, 1990, J PHARMACOL EXP THER, V255, P211
[32]  
ZHANG JS, 1994, J PHARMACOL EXP THER, V269, P509